Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 6

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 6
---
296 
  
    Issuance of common stock upon exercise of Pre-Funded Warrants 
     -  
     -  
     8,326  
     1  
     4,994  
     -  
     -  
     4,995  
     -  
     4,995 
  
    Issuance of shares for RSUs 
     -  
     -  
     3,201  
     -  
     -  
     -  
     -  
     -  
     -  
     - 
  
    Net foreign translation loss 
     -  
     -  
     -  
     -  
     -  
     -  
     (3,894) 
     (3,894) 
     -  
     (3,894)
  
    Net income (loss) 
     -  
     -  
     -  
     -  
     -  
     430,470  
     -  
     430,470  
     (2,485) 
     427,985 
  
    Balance— March 31, 2024 
     78,803  
    $9,858,040  
     196,057  
    $20  
    $29,360,654  
    $(32,150,380) 
    $131,667  
    $7,200,001  
    $(74,523) 
    $7,125,478 

(1)Prior periods presented have been adjusted to reflect the
1:12 reverse stock split on August 12, 2024 and the 1:5 reverse stock split on February 24, 2025.

The accompanying notes are an integral part
of these unaudited consolidated condensed financial statements.

4

60 DEGREES PHARMACEUTICALS, INC.

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)

    For the Three Months Ended March 31, 
    2025  
    2024 
  
    CASH FLOWS FROM OPERATING ACTIVITIES 

    Net (Loss) Income 
    $(1,877,301)